Table of Contents Table of Contents
Previous Page  1836 / 1851 Next Page
Information
Show Menu
Previous Page 1836 / 1851 Next Page
Page Background

Toxicity of concurrent SRT and

MEK-inhibitors

MEK-inhibitors (trametinib)

Very small number of patients

No data

Kroeze S et al. Cancer Treatment Reviews 53 (2017) 25–37